Skip to main content
. Author manuscript; available in PMC: 2024 Sep 1.
Published in final edited form as: Am J Med Genet C Semin Med Genet. 2023 Aug 3;193(3):e32058. doi: 10.1002/ajmg.c.32058
Autism Symptom Level
Baseline 1-Month Follow-Up 4-Month Follow-Up
Total n ASD n r r r
Training 192 42 .53 .42 .54
Testing 76 18 .49 .32 .54
Validation 77 22 .61 .53 .65
Testing + Validation 153 40 .55 .43 .58
 Ages 3–8 64 20 .54 .48 .62
 Ages 9+ 89 20 .57 .37 .59
ASD Diagnosis
Baseline 1-Month Follow-Up 4-Month Follow-Up
Total n ASD n AUC (SE) AUC (SE) AUC (SE)
Training 192 42 .809 (.036) .735 (.041) .804 (.039)
Testing 76 18 .790 (.066) .693 (.073) .755 (.081)
Validation 77 22 .857 (.050) .790 (.067) .883 (.051)
Testing + Validation 153 40 .821 (.041) .744 (.049) .815 (.048)
 Ages 3–8 64 20 .806 (.060) .730 (.072) .836 (.062)
 Ages 9+ 89 20 .833 (.058) .749 (.071) .822 (.072)

Note. ASD=Autism Spectrum Disorder. All correlations are statistically significant, p<.01. The Training sub-sample included a randomly-selected 60% of all administration. The testing and validation sub-samples each consisted of a random selection of 20% of all administration. Autism Symptom Level is based on averaging scores on the social communication / interaction and restricted repetitive behavior scales of the neurobehavioral evaluation tool informant-report survey.